Bellaire Eye & Laser Center introduces LASIK-Laser, a revolutionary technology from Intralase: Better Technology, Better Results, Better Vision
September 13, 2004
The Intralase Laser, a femtosecond laser, replaces the mechanical hand-held microkeratome in creating a precise and safer flap making the LASIK procedure much safer by reducing complications.
See full story.
WaveLight Allegretto WAVE™ Excimer Laser System received FDA approval on October 7, 2003
August 31, 2004
WaveLight Allegretto, manufactured by WaveLight Laser Technologie AG is now available at Warren Cross & Associates/ Bellaire Eye & Laser Center.
More information is available at www.allegretowave.net
FDA approves the Artisan Verisyse™ Phakic IntaOcular Lens
September 12, 2004
In September 2004 the Food and Drug Administration approved the first implantable lens to help patients with high myopia (nearsightedness) who are not suitable candidates for cornea-based related laser procedures (LASIK, PRK, EPILASIK,|INTRALASE). The Verisyse is an iris fixated lens with significant advantages in safety, stability and efficacy.
Phakic Intraocular Lens represents a safe and effective alternative for patients wishing to reduce or eliminate the need for high power glasses or contact lenses. The lens is designed for implantation into the anterior chamber in a phakic eye for the correction of high myopia between -5 to -20 D. The word “phakic” means that your natural crystalline lens is left in the eye. This is important because your natural lens plays an important role in helping your eye adjust between seeing objects that are near and far.
Warren Cross M.D & Associates/ Bellaire Eye LAser Center offers Phakic Intraocular implantable Lens as an option for treatment of neartsightedness up to minus 20 Dioptres, farsightedness up to plus 12 Dioptres and Astigmatism up to 7.5 Dioptres.
Restasis approved as new treatment for dry eye
July 1, 2003
Allergan Pharmaceuticals is proud to announce that Restasis is now available at your local pharmacy.
See full story.
A new study reveals that a person’s choice of soap may play a role in eye infections
July 1, 2003
Using antibacterial/deodorant soap before surgery can reduce the amount of external disease in ocular surgery compared with using nonbacterial soap, said Warren D. Cross, MD, of Bellaire Eye & Laser Center, in Houston.
See full story.
If you are a member of the media, please contact Dr. Luis Lay at 713.666.4224, or e-mail luislay@drcross.com
|
